Suppr超能文献

绿茶多酚表没食子儿茶素-3-没食子酸酯通过67 kDa层粘连蛋白受体的信号通路

Green tea polyphenol epigallocatechin-3-gallate signaling pathway through 67-kDa laminin receptor.

作者信息

Umeda Daisuke, Yano Satomi, Yamada Koji, Tachibana Hirofumi

机构信息

Laboratory of Food Chemistry, Division of Applied Biological Chemistry, Department of Bioscience and Biotechnology, Faculty of Agriculture, Kyushu University, Fukuoka 812-8581, Japan.

Laboratory of Food Chemistry, Division of Applied Biological Chemistry, Department of Bioscience and Biotechnology, Faculty of Agriculture, Kyushu University, Fukuoka 812-8581, Japan; Laboratory of Functional Food Design, Department of Functional Metabolic Design, Bio-Architecture Center, Kyushu University, Fukuoka 812-8581, Japan.

出版信息

J Biol Chem. 2008 Feb 8;283(6):3050-3058. doi: 10.1074/jbc.M707892200. Epub 2007 Dec 12.

Abstract

(-)-Epigallocatechin-3-gallate (EGCG), the principal polyphenol in green tea, has been shown to be a potent chemopreventive agent. Recently, 67-kDa laminin receptor (67LR) has been identified as a cell surface receptor for EGCG that mediates the anticancer activity of EGCG. Indeed, expression of 67LR confers EGCG responsiveness to tumor cells; however, the molecular basis for the anticancer activity of EGCG in vivo is not entirely understood. Here we show that (i) using a direct genetic screen, eukaryotic translation elongation factor 1A (eEF1A) is identified as a component responsible for the anticancer activity of EGCG; (ii) through both eEF1A and 67LR, EGCG induces the dephosphorylation of myosin phosphatase targeting subunit 1 (MYPT1) at Thr-696 and activates myosin phosphatase; and (iii) silencing of 67LR, eEF1A, or MYPT1 in tumor cells results in abrogation of EGCG-induced tumor growth inhibition in vivo. Additionally, we found that eEF1A is up-regulated by EGCG through 67LR. Overall, these findings implicate both eEF1A and MYPT1 in EGCG signaling for cancer prevention through 67LR.

摘要

(-)-表没食子儿茶素-3-没食子酸酯(EGCG)是绿茶中的主要多酚类物质,已被证明是一种有效的化学预防剂。最近,67 kDa层粘连蛋白受体(67LR)已被确定为EGCG的细胞表面受体,介导EGCG的抗癌活性。事实上,67LR的表达赋予肿瘤细胞对EGCG的反应性;然而,EGCG在体内抗癌活性的分子基础尚未完全明确。在此我们表明:(i)通过直接遗传筛选,真核翻译延伸因子1A(eEF1A)被确定为负责EGCG抗癌活性的一个成分;(ii)EGCG通过eEF1A和67LR诱导肌球蛋白磷酸酶靶向亚基1(MYPT1)在苏氨酸696位点去磷酸化并激活肌球蛋白磷酸酶;(iii)在肿瘤细胞中沉默67LR、eEF1A或MYPT1会导致体内EGCG诱导的肿瘤生长抑制作用被消除。此外,我们发现EGCG通过67LR上调eEF1A。总体而言,这些发现表明eEF1A和MYPT1均参与EGCG通过67LR进行癌症预防的信号传导。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验